Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

The relationship between antibiotic use in humans and poultry and antibiotic resistance prevalence in humans: an ecological regression study of<i>Campylobacter</i>in the UK.
Emes, E; Guitian, J; KNIGHT, G; NAYLOR, N;
2024
medRxiv (2024). 10.1101/2024.01.10.24301092.
Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countries.
PREM, K; Cernuschi, T; Malvolti, S; Brisson, M; JIT, M;
2024
EClinicalMedicine, (2024).74, 10.1016/j.eclinm.2024.102735.
Visual preferences for communicating modelling: a study of Covid-19 policy and decision makers.
Hadley, L; Rich, C; Tasker, A; Restif, O; FUNK, S;
2024
Cold Spring Harbor Laboratory (2024). 10.1101/2024.11.05.24316774.
A global dataset of publicly available dengue case count data.
Clarke, J; LIM, A; Gupte, P; Pigott, DM; Van Panhuis, WG; BRADY, OJ;
2024
Scientific Data, (2024).11 1 10.1038/s41597-024-03120-7.
Long-term healthcare utilisation, costs and quality of life after invasive group B <i>Streptococcus</i> disease: a cohort study in five low-income and middle-income countries.
Seedat, F; PROCTER, S; Dangor, Z; Leahy, S; Santhanam, S; John, HB; Bassat, Q; Aerts, C; Abubakar, A; Nasambu, C; Libster, R; Yanotti, CS; PAUL, P; Chanda, J; Gonçalves, BP; Horváth-Puhó, E; LAWN, JE; GBS Long-Term Outcomes LMIC Collaborative Group,; JIT, M;
2024
BMJ global health, (2024).9 5 10.1136/bmjgh-2023-014367.
The contribution of animal antibiotic use to antibiotic resistance in human infections: Panel evidence from Denmark.
Emes, E; Belay, D; KNIGHT, GM;
2024
One Health, (2024).19, 10.1016/j.onehlt.2024.100856.
The contribution of animal antibiotic use to antibiotic resistance in humans: Panel evidence from Denmark.
Emes, E; Belay, D; KNIGHT, G;
2024
medRxiv (2024). 10.1101/2024.01.10.24301091.
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT).
CARLILE, O; BRIGGS, A; Henderson, AD; Butler-Cole, BF C; Tazare, J; TOMLINSON, LA; MARKS, M; JIT, M; Lin, L-Y; Bates, C; Parry, J; Bacon, SC J; Dillingham, I; Dennison, WA; COSTELLO, RE; Walker, AJ; Hulme, W; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; HERRETT, E; EGGO, RM;
2024
The Lancet Regional Health - Europe, (2024).40, 10.1016/j.lanepe.2024.100908.
Corrigendum to "Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024" [Vaccine 42(15) (2024) 3379-3383].
Lambach, P; Silal, S; Sbarra, AN; Koh, M; Aggarwal, R; Farooqui, HH; FLASCHE, S; Hogan, AB; Kim, S-Y; Leung, K; Moss, WJ; Munywoki, PK; Portnoy, A; Sheel, M; Wang, X-Y;
2024
Vaccine, (2024).42 23 10.1016/j.vaccine.2024.07.003.
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches).
Watson, CH; Gsell, P-S; Hall, Y; Camacho, A; Riveros, X; Enwere, G; Vicari, A; Nadlaou, SD; Toure, A; Sani, IM; Diallo, A; Kolie, C; Duraffour, S; Ifono, K; Maomou, A; Dore, K; Djidonou, HA; Bagayoko, A; Damey, PP; Camara, MN; Diallo, FB; Oumar, FT; Toure, K; Diaby, ML; Sylla, L; ... Henao-Restrepo, AM.
2024
BMC medicine, (2024).22 1 10.1186/s12916-024-03726-z.